AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19884549 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU)
Number of subjects: 711
Study 19884549 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU) with irinotecan
Number of subjects: 711
Study 19884549 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU) with oxaliplatin
Number of subjects: 711
Study 19884549 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF mutation
Number of subjects: 711
Study 19884549 — intervention group
Group type: EXPERIMENTAL
Intervention: KRAS/BRAF mutation
Number of subjects: 711
Study 18326980 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/d)
Number of subjects: 30
Study 15936419 — intervention group
Group type: EXPERIMENTAL
Intervention: Three rounds of oral visual inspection by trained health workers at 3-year intervals (intervention group)
Number of subjects: 191873
Study 15936419 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 191873
Study 12183788 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 0
Study 12183788 — intervention group
Group type: COMPARATOR
Intervention: 10 mg depot dexamethasone combined with 60 mg lidocaine
Number of subjects: 0
Study 10332595 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-weighted GRE sequence
Number of subjects: 3
Study 10332595 — intervention group
Group type: COMPARATOR
Intervention: Conventional spin echo (CSE)
Number of subjects: 3
Study 10332595 — intervention group
Group type: COMPARATOR
Intervention: Half-Fourier spin echo (HFSE)
Number of subjects: 3
Study 10332595 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient recalled echo (GRE)
Number of subjects: 3
Study 8758853 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 'Nao An' capsules
Number of subjects: 4793
Study 1745034 — intervention group
Group type: EXPERIMENTAL
Intervention: EOPROTIN
Number of subjects: 28
Study 1745034 — intervention group
Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 28
Study 6357037 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotics
Number of subjects: 200
Study 6357037 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (Control)
Number of subjects: 200
Study 6357037 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound infection
Number of subjects: 200
Study 6357037 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoiding antibiotic prophylaxis
Number of subjects: 200
Study 29543123 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 23
Study 29543123 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐administered Foam Rolling (SAFR)
Number of subjects: 23
Study 29543123 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 23
Study 28089316 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 1376
Study 28089316 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (time-dependent variable)
Number of subjects: 1376
Study 26102300 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC containing ocular lubricants
Number of subjects: 49
Study 26102300 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer containing ocular lubricants
Number of subjects: 49
Study 26102300 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HPMC and povidone
Number of subjects: 49
Study 26102300 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone
Number of subjects: 49
Study 26102300 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 49
Study 24408214 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (35 mg) nicotine patch
Number of subjects: 185
Study 24408214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 21944677 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative ECG analysis
Number of subjects: 5420
Study 21944677 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative ECG analysis
Number of subjects: 5420
Study 19200452 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high-dose regimen (1 x 12 microg)
Number of subjects: 0
Study 19200452 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (2 doses of 6 microg with a 28-day interval)
Number of subjects: 0
Study 17971615 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Dynamic Posturography (CDP) therapy
Number of subjects: 15
Study 17971615 — intervention group
Group type: COMPARATOR
Intervention: Standard Physical Therapy (PT)
Number of subjects: 15
Study 15114200 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating-water garment
Number of subjects: 9
Study 15114200 — intervention group
Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 9
Study 11209831 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed duration of exposure using diary method
Number of subjects: 10
Study 11209831 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed duration of exposure using interview method
Number of subjects: 10
Study 11209831 — intervention group
Group type: COMPARATOR
Intervention: Measured total daily exposure time
Number of subjects: 10
Study 9743393 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine-bupivacaine (0.05 mg/kg epidural morphine and 5 ml 0.25% bupivacaine followed by an infusion of 0.125% bupivacaine with 0.1% morphine)
Number of subjects: 40
Study 9743393 — intervention group
Group type: COMPARATOR
Intervention: Intravenous PCA morphine sulfate (0.1 mg/kg)
Number of subjects: 40
Study 9743393 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine-bupivacaine
Number of subjects: 40
Study 9743393 — intervention group
Group type: COMPARATOR
Intervention: Intravenous PCA morphine sulfate
Number of subjects: 40
Study 7803223 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet A (UVA) phototherapy
Number of subjects: 22
Study 7803223 — intervention group
Group type: COMPARATOR
Intervention: Trimethylpsoralen UVA (PUVA) photochemotherapy
Number of subjects: 22
Study 7803223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 3053788 — intervention group
Group type: COMPARATOR
Intervention: Root scaling and planing with removal of all cementum in control quadrants
Number of subjects: 11
Study 3053788 — intervention group
Group type: EXPERIMENTAL
Intervention: Polishing of root surfaces without cementum removal in test quadrants
Number of subjects: 11
Study 30257983 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) programme
Number of subjects: 278
Study 30257983 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 278
Study 28578639 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus abiraterone acetate (1000 mg daily) and prednisolone (5 mg daily)
Number of subjects: 1917
Study 28578639 — intervention group
Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 1917
Study 26632686 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapularis transthoracic approach (Group A, n = 21)
Number of subjects: 43
Study 26632686 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral approach (Group B, n = 22)
Number of subjects: 43
Study 23967796 — intervention group
Group type: EXPERIMENTAL
Intervention: VELscope® (autofluorescence visualization device)
Number of subjects: 120
Study 23967796 — intervention group
Group type: COMPARATOR
Intervention: Conventional white-light examination
Number of subjects: 120
Study 21030491 — intervention group
Group type: COMPARATOR
Intervention: TBNA without ROSE
Number of subjects: 168
Study 21030491 — intervention group
Group type: EXPERIMENTAL
Intervention: TBNA with ROSE
Number of subjects: 168
Study 18283250 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 25
Study 17201848 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation
Number of subjects: 135
Study 17201848 — intervention group
Group type: COMPARATOR
Intervention: High BNP concentration (>18.4 pg/mL)
Number of subjects: 135
Study 17201848 — intervention group
Group type: COMPARATOR
Intervention: Plasma BNP concentration
Number of subjects: 135
Study 14583182 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 type II DM patients
Number of subjects: 60
Study 14583182 — intervention group
Group type: COMPARATOR
Intervention: 30 normal controls
Number of subjects: 60
Study 14583182 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 patients with abnormal myocardial perfusion
Number of subjects: 60
Study 14583182 — intervention group
Group type: COMPARATOR
Intervention: 36 patients with normal myocardial perfusion
Number of subjects: 60
Study 14583182 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 patients with more cardiovascular risk factors
Number of subjects: 60
Study 14583182 — intervention group
Group type: COMPARATOR
Intervention: 22 patients with less cardiovascular risk factors
Number of subjects: 60
Study 10573332 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) beverage
Number of subjects: 8
Study 10573332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) beverage
Number of subjects: 8
Study 8759075 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (60 to 90 mg TID)
Number of subjects: 186
Study 1890860 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 14
Study 1890860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6750282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmetin (1,200 mg/day)
Number of subjects: 12
Study 6750282 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (2,000 mg/day)
Number of subjects: 12
Study 31936767 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based nutrition education and physical activity intervention (8 months)
Number of subjects: 171
Study 31936767 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted)
Number of subjects: 171
Study 29509640 — intervention group
Group type: EXPERIMENTAL
Intervention: High amount high intensity exercise
Number of subjects: 216
Study 29509640 — intervention group
Group type: EXPERIMENTAL
Intervention: High amount low intensity exercise
Number of subjects: 216
Study 29509640 — intervention group
Group type: EXPERIMENTAL
Intervention: Low amount low intensity exercise
Number of subjects: 216
Study 29509640 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 216
Study 29509640 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (combined)
Number of subjects: 216
Study 28190762 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) with surgery within 1 week
Number of subjects: 840
Study 28190762 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy with delay (5 × 5 Gy) with surgery after 4-8 weeks
Number of subjects: 840
Study 28190762 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-course radiotherapy with delay (25 × 2 Gy) with surgery after 4-8 weeks
Number of subjects: 840
Study 28190762 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy with delay
Number of subjects: 840
Study 28190762 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy
Number of subjects: 840
Study 28190762 — intervention group
Group type: COMPARATOR
Intervention: Long-course radiotherapy with delay
Number of subjects: 840
Study 28190762 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy with delay vs short-course radiotherapy
Number of subjects: 840
Study 26208329 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation without any defibrillation threshold (DFT) testing
Number of subjects: 194
Study 26208329 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified 'upper limit of vulnerability (ULV) testing'
Number of subjects: 194
Study 26208329 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional safety margin testing including ventricular arrhythmia induction
Number of subjects: 194
Study 26208329 — intervention group
Group type: COMPARATOR
Intervention: Control group (ICD implantation without DFT testing)
Number of subjects: 194
Study 24114668 — intervention group
Group type: COMPARATOR
Intervention: Continuous erlotinib (100 mg daily)
Number of subjects: 60
Study 24114668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent erlotinib (150 mg on alternate days from day 2 to 14, then 150 mg daily on days 15 to 21)
Number of subjects: 60
Study 24114668 — intervention group
Group type: COMPARATOR
Intervention: Continuous erlotinib
Number of subjects: 60
Study 24114668 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent erlotinib
Number of subjects: 60
Study 22120894 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg ginkgo extract tablets, three times daily for 30 days
Number of subjects: 32
Study 22120894 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 32
Study 18369175 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 20000
Study 18369175 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 20000
Study 18369175 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and extended-release dipyridamole
Number of subjects: 20000
Study 18369175 — intervention group
Group type: COMPARATOR
Intervention: Cilostazole
Number of subjects: 20000
Study 18369175 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel combined
Number of subjects: 20000
Study 16938913 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental meditation program
Number of subjects: 0
Study 16938913 — intervention group
Group type: EXPERIMENTAL
Intervention: Maharishi Consciousness-Based Health Care
Number of subjects: 0
Study 14551376 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU)
Number of subjects: 8
Study 14551376 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 8
Study 10857524 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise intervention (6-week program)
Number of subjects: 24
Study 10857524 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole 12 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole 20 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole 24 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 4 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 8 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 16 mg/day
Number of subjects: 497
Study 9167505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 497
Study 9167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 497
Study 7681897 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 24
Study 7681897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydralazine
Number of subjects: 24
Study 7681897 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 24
Study 7681897 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (6 mg/day)
Number of subjects: 24
Study 7681897 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (2.5, 5.0, and 10.0 micrograms/kg/min)
Number of subjects: 24
Study 3511104 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 18
Study 3511104 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (2 g single dose)
Number of subjects: 18
Study 3511104 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18
Study 30893353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR)
Number of subjects: 43
Study 30893353 — intervention group
Group type: EXPERIMENTAL
Intervention: Detached Mindfulness (DM)
Number of subjects: 43
Study 30893353 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 43
Study 29907818 — intervention group
Group type: EXPERIMENTAL
Intervention: Speckle tracking echocardiography (STE) during semisupine cycle ergometric stress echocardiography
Number of subjects: 127
Study 29907818 — intervention group
Group type: EXPERIMENTAL
Intervention: Speckle tracking echocardiography (STE)
Number of subjects: 127
Study 26197260 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational handout
Number of subjects: 42
Study 26197260 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 23807186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery plus intraoperative ranibizumab injection
Number of subjects: 80
Study 23807186 — intervention group
Group type: COMPARATOR
Intervention: Sham group (cataract surgery only)
Number of subjects: 80
Study 23318050 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 12 weeks, 3 times a week
Number of subjects: 36
Study 23318050 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) for 12 weeks, no training
Number of subjects: 36
Study 21161480 — intervention group
Group type: EXPERIMENTAL
Intervention: Dortmund Developmental Screening for Preschools (DESK 3-6)
Number of subjects: 71
Study 21161480 — intervention group
Group type: EXPERIMENTAL
Intervention: KiK training for preschool teachers
Number of subjects: 71
Study 21161480 — intervention group
Group type: EXPERIMENTAL
Intervention: KiK training
Number of subjects: 71
Study 21161480 — intervention group
Group type: EXPERIMENTAL
Intervention: DESK and training
Number of subjects: 71
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 439
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 439
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 439
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Total WMH volume
Number of subjects: 439
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcortical WMH volume
Number of subjects: 439
Study 18753745 — intervention group
Group type: EXPERIMENTAL
Intervention: Periventricular WMH volume
Number of subjects: 439
Study 17081355 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of autologous bone marrow mononuclear cells (BM‐MNCs)
Number of subjects: 184
Study 17081355 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride concluding heparin (control)
Number of subjects: 184
Study 14692654 — intervention group
Group type: EXPERIMENTAL
Intervention: TOR60 (60 mg daily)
Number of subjects: 648
Study 14692654 — intervention group
Group type: EXPERIMENTAL
Intervention: TOR200 (200 mg daily)
Number of subjects: 648
Study 14692654 — intervention group
Group type: EXPERIMENTAL
Intervention: TAM20 (20 mg daily)
Number of subjects: 648
Study 11013867 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking group (mean cotinine concentration 1039 +/- 560 mg/L in serum)
Number of subjects: 75
Study 11013867 — intervention group
Group type: COMPARATOR
Intervention: Non-smoking group (mean cotinine concentration not specified)
Number of subjects: 75
Study 8775368 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendinitis group
Number of subjects: 60
Study 8775368 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal dystonia group
Number of subjects: 60
Study 8775368 — intervention group
Group type: COMPARATOR
Intervention: Healthy adult control group
Number of subjects: 60
Study 8775368 — intervention group
Group type: COMPARATOR
Intervention: Healthy musician control group
Number of subjects: 60
Study 1321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (160 micrograms kg‐1 body weight)
Number of subjects: 12
Study 1321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (3 mg)
Number of subjects: 12
Study 1321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron and Haloperidol (combined)
Number of subjects: 12
Study 1321654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 4028282 — intervention group
Group type: COMPARATOR
Intervention: Tinidazole 2 g daily taken orally in two separate doses for two consecutive days
Number of subjects: 60
Study 4028282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole with the same regimen
Number of subjects: 60
Study 30923164 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention model of care (bedside management within 24 h of admission)
Number of subjects: 1002
Study 30923164 — intervention group
Group type: COMPARATOR
Intervention: Usual care (referral‐based consultation service)
Number of subjects: 1002
Study 29495655 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical interdental device combined with manual toothbrush
Number of subjects: 22
Study 29495655 — intervention group
Group type: COMPARATOR
Intervention: Manual brushing alone (Control)
Number of subjects: 22
Study 27468840 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) at 50 mA
Number of subjects: 13
Study 27468840 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) at 40 mA
Number of subjects: 13
Study 27468840 — intervention group
Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 13
Study 24616359 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad public release consent
Number of subjects: 113
Study 24616359 — intervention group
Group type: EXPERIMENTAL
Intervention: Data sharing preferences
Number of subjects: 113
Study 24616359 — intervention group
Group type: EXPERIMENTAL
Intervention: Data sharing concerns
Number of subjects: 113
Study 21311362 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body (WB) precooling
Number of subjects: 10
Study 21311362 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body (WB) and head + hand (HH) cooling
Number of subjects: 10
Study 21311362 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body (WB) cooling
Number of subjects: 10
Study 21311362 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 10